Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Christopher Baugh, MD, MBA

Vice Chair of Clinical Affairs
Department of Emergency Medicine
Brigham and Women's Hospital
Associate Professor
Harvard Medical School
Boston, Massachusetts

Disclosures

Christopher Baugh, MD, MBA, has the following relevant financial relationships:
Consultant or advisor for: Roche Diagnostics
Speaker or member of speakers bureau for: Roche Diagnostics
Research funding from: Visby Medical
Owns stock (privately owned) in: Lucia Health Guidelines

Natalie Kreitzer, MD, MS

Associate Professor of Emergency Medicine, Neurocritical Care
Medical Director of Stroke Services
West Chester Hospital
University of Cincinnati
Cincinnati, Ohio

Disclosures

Natalie Kreitzer, MD, MS, has the following relevant financial relationships:
Consultant or advisor for: PhaseBio Pharmaceuticals, Inc.
Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP

Truman Milling, Jr, MD, FACEP

Associate Professor
Department of Neurology
Associate Professor
Department of Surgery and Perioperative Care
Research Scholar
Emergency Medicine Residency
Seton Dell Medical School Stroke Institute
Austin, Texas

Disclosures

Truman Milling, Jr, MD, FACEP, has the following relevant financial relationships:
Consultant or advisor for: Cellphire; CSL Behring; Octapharma; Portola Pharmaceuticals, Inc./Alexion Pharmaceuticals, Inc./AstraZeneca Pharmaceuticals LP
Speaker or member of speakers bureau for: CSL Behring; Octapharma; Portola Pharmaceuticals, Inc./Alexion Pharmaceuticals, Inc./AstraZeneca Pharmaceuticals LP

Editors

Asha P. Gupta, PharmD, RPh

Associate Medical Education Director, Medscape, LLC

Disclosures

Asha P. Gupta, PharmD, RPh, has no relevant financial relationships.

Frederick Stange, DO

Scientific Content Manager, Medscape, LLC

Disclosures

Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer

Susan L. Smith, MN, PhD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Susan L. Smith, MN, PhD, has no relevant financial relationships.

CME / ABIM MOC

Demystifying Anticoagulation Reversal in Bleeding Management: Quick Tips for the Busy Clinician

Authors: Christopher Baugh, MD, MBA; Natalie Kreitzer, MD, MS; Truman Milling, Jr, MD, FACEP
CME / ABIM MOC Released: 6/24/2022
Valid for credit through: 6/24/2023

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates - maximum of 0.50 ABIM MOC points

You Are Eligible For
- Letter of Completion
- ABIM MOC points

Target Audience and Goal Statement

This activity is intended for emergency medicine physicians, surgeons, and critical-care specialists.

The goal of this activity is for learners to enhance their understanding of bleeding management strategies for patients on oral anticoagulant (OAC) therapy who may experience major bleeding.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Burden of OAC-related major bleeding in the emergency department (ED)
- Guideline recommendations for the appropriate use of reversal agents for managing OAC-associated major bleeds
- Clinical data demonstrating the efficacy and safety of reversal agents in the management of OAC-associated major bleeds
- Multidisciplinary strategies to effectively manage major bleeding in the ED
Have greater competence related to
- Diagnosing and monitoring for major bleeding
- Integrating a reversal strategy in the presence of an OAC-related bleed in appropriate patients

Disclosures

Faculty

Christopher Baugh, MD, MBA

Vice Chair of Clinical Affairs
Department of Emergency Medicine
Brigham and Women's Hospital
Associate Professor
Harvard Medical School
Boston, Massachusetts

Disclosures

Christopher Baugh, MD, MBA, has the following relevant financial relationships:
Consultant or advisor for: Roche Diagnostics
Speaker or member of speakers bureau for: Roche Diagnostics
Research funding from: Visby Medical
Owns stock (privately owned) in: Lucia Health Guidelines

Natalie Kreitzer, MD, MS

Associate Professor of Emergency Medicine, Neurocritical Care
Medical Director of Stroke Services
West Chester Hospital
University of Cincinnati
Cincinnati, Ohio

Disclosures

Natalie Kreitzer, MD, MS, has the following relevant financial relationships:
Consultant or advisor for: PhaseBio Pharmaceuticals, Inc.
Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP

Truman Milling, Jr, MD, FACEP

Associate Professor
Department of Neurology
Associate Professor
Department of Surgery and Perioperative Care
Research Scholar
Emergency Medicine Residency
Seton Dell Medical School Stroke Institute
Austin, Texas

Disclosures

Truman Milling, Jr, MD, FACEP, has the following relevant financial relationships:
Consultant or advisor for: Cellphire; CSL Behring; Octapharma; Portola Pharmaceuticals, Inc./Alexion Pharmaceuticals, Inc./AstraZeneca Pharmaceuticals LP
Speaker or member of speakers bureau for: CSL Behring; Octapharma; Portola Pharmaceuticals, Inc./Alexion Pharmaceuticals, Inc./AstraZeneca Pharmaceuticals LP

Editors

Asha P. Gupta, PharmD, RPh

Associate Medical Education Director, Medscape, LLC

Disclosures

Asha P. Gupta, PharmD, RPh, has no relevant financial relationships.

Frederick Stange, DO

Scientific Content Manager, Medscape, LLC

Disclosures

Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer

Susan L. Smith, MN, PhD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Susan L. Smith, MN, PhD, has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Emergency Medicine

CME / ABIM MOC

Demystifying Anticoagulation Reversal in Bleeding Management: Quick Tips for the Busy Clinician

Authors: Christopher Baugh, MD, MBA; Natalie Kreitzer, MD, MS; Truman Milling, Jr, MD, FACEPFaculty and Disclosures

CME / ABIM MOC Released: 6/24/2022

Valid for credit through: 6/24/2023

processing....

Select Any Chapter to Begin

Clinician Handout

Page 1 of 25

The Burden of Life-Threatening Bleeding in Anticoagulated Patients - Pre-Assessment

Earn Credit CME / ABIM MOC Information

Activity Transcript

PDF Downloads

Clinician Handout

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Christopher Baugh, MD, MBA

Natalie Kreitzer, MD, MS

Truman Milling, Jr, MD, FACEP

Editors

Asha P. Gupta, PharmD, RPh

Frederick Stange, DO

Compliance Reviewer

Susan L. Smith, MN, PhD

CME / ABIM MOC

Demystifying Anticoagulation Reversal in Bleeding Management: Quick Tips for the Busy Clinician

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Christopher Baugh, MD, MBA

Natalie Kreitzer, MD, MS

Truman Milling, Jr, MD, FACEP

Editors

Asha P. Gupta, PharmD, RPh

Frederick Stange, DO

Compliance Reviewer

Susan L. Smith, MN, PhD

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Demystifying Anticoagulation Reversal in Bleeding Management: Quick Tips for the Busy Clinician

Select Any Chapter to Begin

Clinician Handout

PDF Downloads